vs

Side-by-side financial comparison of MediWound Ltd. (MDWD) and SMITH MICRO SOFTWARE, INC. (SMSI). Click either name above to swap in a different company.

MediWound Ltd. is the larger business by last-quarter revenue ($5.7M vs $4.0M, roughly 1.4× SMITH MICRO SOFTWARE, INC.). On growth, MediWound Ltd. posted the faster year-over-year revenue change (12.7% vs -20.0%).

MediWound Ltd. is a biopharmaceutical company specializing in the research, development, production and commercialization of innovative products for burn care, chronic wound treatment and soft tissue repair. It operates mainly across North America, Europe and Asia, serving hospitals, healthcare providers and patients in the wound care segment.

Smith Micro Software, Inc., founded in 1982 by William W. Smith, Jr., is a developer and marketer of both enterprise and consumer-level software and services. Headquartered in Pittsburgh, Pennsylvania, Smith Micro maintains multiple domestic and international offices. United States locations include Aliso Viejo, California, and Pittsburgh, Pennsylvania. International offices are located throughout Europe and Asia. Currently, the company focuses on digital lifestyle solutions and security tech...

MDWD vs SMSI — Head-to-Head

Bigger by revenue
MDWD
MDWD
1.4× larger
MDWD
$5.7M
$4.0M
SMSI
Growing faster (revenue YoY)
MDWD
MDWD
+32.7% gap
MDWD
12.7%
-20.0%
SMSI

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
MDWD
MDWD
SMSI
SMSI
Revenue
$5.7M
$4.0M
Net Profit
$-13.3M
Gross Margin
23.5%
76.4%
Operating Margin
-100.1%
-109.8%
Net Margin
-233.3%
Revenue YoY
12.7%
-20.0%
Net Profit YoY
-111.2%
EPS (diluted)
$-1.23
$-0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MDWD
MDWD
SMSI
SMSI
Q4 25
$4.0M
Q3 25
$4.3M
Q2 25
$5.7M
$4.4M
Q1 25
$4.6M
Q4 24
$5.0M
Q3 24
$4.6M
Q2 24
$5.1M
$5.1M
Q1 24
$5.8M
Net Profit
MDWD
MDWD
SMSI
SMSI
Q4 25
Q3 25
$-4.5M
Q2 25
$-13.3M
$-15.1M
Q1 25
$-5.2M
Q4 24
Q3 24
$-6.4M
Q2 24
$-6.3M
$-6.9M
Q1 24
$-31.0M
Gross Margin
MDWD
MDWD
SMSI
SMSI
Q4 25
76.4%
Q3 25
73.9%
Q2 25
23.5%
73.5%
Q1 25
72.8%
Q4 24
75.6%
Q3 24
71.6%
Q2 24
8.8%
68.7%
Q1 24
65.7%
Operating Margin
MDWD
MDWD
SMSI
SMSI
Q4 25
-109.8%
Q3 25
-103.2%
Q2 25
-100.1%
-338.3%
Q1 25
-112.7%
Q4 24
-89.7%
Q3 24
-140.0%
Q2 24
-88.6%
-135.8%
Q1 24
-542.4%
Net Margin
MDWD
MDWD
SMSI
SMSI
Q4 25
Q3 25
-104.3%
Q2 25
-233.3%
-340.8%
Q1 25
-112.1%
Q4 24
Q3 24
-137.0%
Q2 24
-124.5%
-134.8%
Q1 24
-534.8%
EPS (diluted)
MDWD
MDWD
SMSI
SMSI
Q4 25
$-0.15
Q3 25
$-0.25
Q2 25
$-1.23
$-0.78
Q1 25
$-0.28
Q4 24
$0.54
Q3 24
$-0.54
Q2 24
$-0.68
$-0.66
Q1 24
$-3.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MDWD
MDWD
SMSI
SMSI
Cash + ST InvestmentsLiquidity on hand
$1.1M
$1.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$20.1M
$18.4M
Total Assets
$67.0M
$25.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MDWD
MDWD
SMSI
SMSI
Q4 25
$1.5M
Q3 25
$1.4M
Q2 25
$1.1M
$1.4M
Q1 25
$2.3M
Q4 24
$2.8M
Q3 24
$1.5M
Q2 24
$3.8M
$5.6M
Q1 24
$6.2M
Stockholders' Equity
MDWD
MDWD
SMSI
SMSI
Q4 25
$18.4M
Q3 25
$19.9M
Q2 25
$20.1M
$22.4M
Q1 25
$36.6M
Q4 24
$40.8M
Q3 24
$37.7M
Q2 24
$17.9M
$42.9M
Q1 24
$45.4M
Total Assets
MDWD
MDWD
SMSI
SMSI
Q4 25
$25.0M
Q3 25
$27.1M
Q2 25
$67.0M
$29.6M
Q1 25
$43.4M
Q4 24
$48.0M
Q3 24
$46.2M
Q2 24
$57.3M
$53.0M
Q1 24
$55.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MDWD
MDWD
SMSI
SMSI
Operating Cash FlowLast quarter
$-5.8M
$-2.2M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MDWD
MDWD
SMSI
SMSI
Q4 25
$-2.2M
Q3 25
$-2.1M
Q2 25
$-5.8M
$-2.3M
Q1 25
$-602.0K
Q4 24
$-4.9M
Q3 24
$-3.8M
Q2 24
$-3.6M
$-4.2M
Q1 24
$-1.3M
Free Cash Flow
MDWD
MDWD
SMSI
SMSI
Q4 25
Q3 25
$-2.2M
Q2 25
Q1 25
$-606.0K
Q4 24
$-4.9M
Q3 24
$-3.8M
Q2 24
$-4.2M
Q1 24
$-1.3M
FCF Margin
MDWD
MDWD
SMSI
SMSI
Q4 25
Q3 25
-49.6%
Q2 25
Q1 25
-13.1%
Q4 24
-99.2%
Q3 24
-82.2%
Q2 24
-82.0%
Q1 24
-23.3%
Capex Intensity
MDWD
MDWD
SMSI
SMSI
Q4 25
Q3 25
0.5%
Q2 25
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.1%
Q2 24
0.1%
Q1 24
0.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MDWD
MDWD

Segment breakdown not available.

SMSI
SMSI

Family Safety$3.2M80%
Other$797.0K20%

Related Comparisons